154 related articles for article (PubMed ID: 3971361)
1. Immunotherapeutic potential in murine tumor models of polyinosinic-polycytidylic acid and poly-L-lysine solubilized by carboxymethylcellulose.
Talmadge JE; Adams J; Phillips H; Collins M; Lenz B; Schneider M; Chirigos M
Cancer Res; 1985 Mar; 45(3):1066-72. PubMed ID: 3971361
[TBL] [Abstract][Full Text] [Related]
2. Optimization of an immunotherapeutic protocol with poly(I,C)-LC.
Talmadge JE; Hartmann D
J Biol Response Mod; 1985 Oct; 4(5):484-9. PubMed ID: 4078594
[TBL] [Abstract][Full Text] [Related]
3. [Antitumor effect of Corynebacterium parvum and poly ICLC on experimental brain tumors].
Kiya K; Kitaoka T; Okamoto H; Harada K; Uozumi T; Toge T; Hattori T; Machida H
Neurol Med Chir (Tokyo); 1983 Nov; 23(11):841-8. PubMed ID: 6201759
[No Abstract] [Full Text] [Related]
4. Pharmacokinetic and therapeutic activity of polyinosinic-polycytidylic acid stabilized with poly-L-lysine in carboxymethylcellulose [poly(I,C)-LC].
Chirigos MA; Schlick E; Ruffmann R; Budzynski W; Sinibaldi P; Gruys E
J Biol Response Mod; 1985 Dec; 4(6):621-7. PubMed ID: 4087033
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of polyinosinic-polycytidylic and poly-L-lysine in metastatic breast cancer.
Theriault RL; Hortobagyi GN; Buzdar AU; Levy HB; Hersh EM
Cancer Treat Rep; 1986 Nov; 70(11):1341-2. PubMed ID: 3768878
[No Abstract] [Full Text] [Related]
6. [Effect of a modified polyinosinic acid--polycytidylic acid complex against herpes simplex keratitis in monkeys (author's transl)].
Teranishi H
Nippon Ganka Gakkai Zasshi; 1980 Sep; 84(9):1198-204. PubMed ID: 7223554
[No Abstract] [Full Text] [Related]
7. Effect of tumor burden and route of administration on the immunotherapeutic properties of polyinosinic-polycytidylic acid stabilized with poly-L-lysine in carboxymethyl cellulose [Poly(I,C)-LC].
Black PL; Hartmann D; Pennington R; Phillips H; Schneider M; Tribble HR; Talmadge JE
Int J Immunopharmacol; 1992 Nov; 14(8):1341-53. PubMed ID: 1464467
[TBL] [Abstract][Full Text] [Related]
8. Immunomodulatory effects in mice of polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose.
Talmadge JE; Adams J; Phillips H; Collins M; Lenz B; Schneider M; Schlick E; Ruffmann R; Wiltrout RH; Chirigos MA
Cancer Res; 1985 Mar; 45(3):1058-65. PubMed ID: 3155990
[TBL] [Abstract][Full Text] [Related]
9. The effect of interferon on rabies infection of animals.
Baer GM
Tex Rep Biol Med; 1981-1982; 41():526-31. PubMed ID: 6189218
[No Abstract] [Full Text] [Related]
10. Enhanced therapeutic efficacy of poly(ICLC) and ribavirin combinations against Rift Valley fever virus infection in mice.
Kende M; Lupton HW; Rill WL; Levy HB; Canonico PG
Antimicrob Agents Chemother; 1987 Jul; 31(7):986-90. PubMed ID: 3662477
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic and therapeutic efficacy of poly(I,C)-LC against Rift Valley fever virus infection in mice.
Kende M
J Biol Response Mod; 1985 Oct; 4(5):503-11. PubMed ID: 2416883
[TBL] [Abstract][Full Text] [Related]
12. Ranking of prophylactic efficacy of poly(ICLC) against Rift Valley fever virus infection in mice by incremental relative risk of death.
Kende M; Lupton HW; Rill WL; Gibbs P; Levy HB; Canonico PG
Antimicrob Agents Chemother; 1987 Aug; 31(8):1194-8. PubMed ID: 3631943
[TBL] [Abstract][Full Text] [Related]
13. Phase I trials of poly(I,C) complexes in advanced cancer.
Krown SE; Kerr D; Stewart WE; Field AK; Oettgen HF
J Biol Response Mod; 1985 Dec; 4(6):640-9. PubMed ID: 2418162
[TBL] [Abstract][Full Text] [Related]
14. Treatment of recurrent laryngeal papillomatosis with an artificial interferon inducer (poly ICLC).
Leventhal BG; Kashima H; Levine AS; Levy HB
J Pediatr; 1981 Oct; 99(4):614-6. PubMed ID: 7277106
[No Abstract] [Full Text] [Related]
15. Comparison of immunomodulatory and immunotherapeutic properties of biologic response modifiers.
Talmadge JE; Chirigos MA
Springer Semin Immunopathol; 1985; 8(4):429-43. PubMed ID: 3879016
[No Abstract] [Full Text] [Related]
16. Treatment of advanced ovarian cancer with polyinosinic-polycytidylic lysine carboxymethylcellulose (poly(ICLC)).
Rettenmaier MA; Berman ML; DiSaia PJ
Gynecol Oncol; 1986 Jul; 24(3):359-61. PubMed ID: 3721308
[TBL] [Abstract][Full Text] [Related]
17. Phase I-II trials of poly(ICLC) in malignant brain tumor patients.
Nakamura O; Shitara N; Matsutani M; Takakura K; Machida H
J Interferon Res; 1982; 2(1):1-4. PubMed ID: 6180095
[TBL] [Abstract][Full Text] [Related]
18. [Effect of interferon inducer (poly ICLC) in the treatment of malignant brain tumor (author's transl)].
Nakamura O; Shitara N; Matsutani M; Takakura K; Machida H
No To Shinkei; 1982 Mar; 34(3):267-73. PubMed ID: 7093065
[TBL] [Abstract][Full Text] [Related]
19. Response of mouse tumor to interferon inducer and radiation.
Lvovsky EA; Mossman KL; Levy HB; Dritschilo A
Int J Radiat Oncol Biol Phys; 1985 Sep; 11(9):1721-5. PubMed ID: 4030439
[TBL] [Abstract][Full Text] [Related]
20. An effective rabies treatment in exposed monkeys: a single dose of interferon inducer and vaccine.
Baer GM; Moore SA; Shaddock JH; Levy HB
Bull World Health Organ; 1979; 57(5):807-13. PubMed ID: 120234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
